David Weiss | Director Corporate Development
Telesis Bio -

David Weiss is the Director of Corporate Development at Telesis Bio where he is focused on bringing cutting edge synthetic biology technologies, such as the Gibson SOLA Platform, to the market to revolutionize the way in which researchers are able to achieve their development goals. With over 20 years in the genomic and synthetic biology markets, he leverages his expertise to drive strategic growth and foster partnerships that propel advancements in diagnostic and therapeutic development. With a proven track record including successfully guiding customers through the complexities of developing cutting-edge diagnostics and therapies, he is able to ensure that innovative solutions are not only conceptualized but also effectively brought to market.